Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Brain : a journal of neurology

• Publication date

  2000-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/BRAIN/123.11.2289PMID 11050028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor Neuron Disease

  2011cited by this paper
• Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)

  2000cited by this paper
• Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study.

  2000cited by this paper
• 11C-flumazenil PET in neocortical epilepsy

  1998cited by this paper
• Stereology: A Practical Primer for Neuropathology

  1998cited by this paper
• In vivo [11C] flumazenil‐PET correlates with ex vivo [3H] flumazenil autoradiography in hippocampal sclerosis

  1998cited by this paper
• Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.

  1997cited by this paper
• Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

  1996cited by this paper
• Frontal lobe dementia and motor neuron disease.

  1996cited by this paper
• Stereotaxic Summation Analysis of Human Cerebral Benzodiazepine Binding Maps

  1996cited by this paper
• Nonverbal visual attention, but not recognition memory of learning, processes are impaired in motor neurone disease.

  1996cited by this paper
• Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.

  1996cited by this paper
• Motor neurone disease-inclusion dementia.

  1996cited by this paper
• Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An 11C‐flumazenil PET study

  1996cited by this paper
• A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis.

  1995cited by this paper
• Spatial registration and normalization of images

  1995cited by this paper
• Hereditary spastic paraparesis with dementia, amyotrophy and peripheral neuropathy. A neuropathological study

  1995cited by this paper
• PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy.

  1995cited by this paper
• Pathology of Motor System Disorder

  1995cited by this paper
• El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic

  1994cited by this paper
• El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• Assessing the significance of focal activations using their spatial extent

  1994cited by this paper
• Motor neuron disease in a defined English population: estimates of incidence and mortality.

  1994cited by this paper
• Frontal lobe atrophy in motor neuron diseases.

  1994cited by this paper
• Cerebral blood flow and oxygen metabolism in progressive dementia associated with amyotrophic lateral sclerosis.

  1993cited by this paper
• Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

  1993cited by this paper
• Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.

  1993cited by this paper
• Spectral Analysis of Dynamic PET Studies

  1993cited by this paper
• Parvalbumin and calbindin D‐28k in the human motor system and in motor neuron disease

  1993cited by this paper
• The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

  1993cited by this paper
• Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: A comparative study

  1993cited by this paper
• Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis: as assessed by serial computed tomography and magnetic resonance imaging.

  1993cited by this paper
• Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study

  1992cited by this paper
• Cerebral glucose utilization in motor neuron disease.

  1992cited by this paper
• Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study.

  1992cited by this paper
• 3D acquisition and reconstruction in positron emission tomography

  1992cited by this paper
• Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

  1992cited by this paper
• Physical performance of a positron tomograph for brain imaging with retractable septa.

  1992cited by this paper
• Analogous filters for beam shaping in diagnostic radiology.

  1992cited by this paper
• The origin of corticospinal projections from the premotor areas in the frontal lobe

  1991cited by this paper
• Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography

  1991cited by this paper
• The Relationship between Global and Local Changes in PET Scans

  1990cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• ANALYZE: a software system for biomedical image analysis

  1990influential reference
• Frontal lobe dementia and motor neuron disease.

  1990cited by this paper
• Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state.

  1989cited by this paper
• Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease.

  1989cited by this paper
• Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study.

  1988cited by this paper
• Presenile dementia combined with amyotrophy: a review of 34 Japanese cases.

  1987cited by this paper
• Brain glutamate deficiency in amyotrophic lateral sclerosis

  1987cited by this paper
• Lowered cerebral glucose utilization in amyotrophic lateral sclerosis

  1987cited by this paper
• Neuropsychological study of motor neuron disease.

  1986cited by this paper
• Cognitive impairment in motor neuron disease

  1985cited by this paper
• Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography.

  1984cited by this paper
• Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies

  1984cited by this paper
• Pathology of amyotrophic lateral sclerosis.

  1982cited by this paper
• Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review.

  1981cited by this paper
• The 'dying back' process. A common denominator in many naturally occurring and toxic neuropathies.

  1979cited by this paper
• The 'dying back' process. A common denominator in many naturally occurring and toxic neuropathies.

  1979cited by this paper
• Free amino acids in motor cortex of amyotrophic lateral sclerosis

  1979cited by this paper
• The central nervous system in motor neurone disease

  1970cited by this paper
• NERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS

  1960cited by this paper
• Electromyographic studies in amyotrophic lateral sclerosis.

  1957cited by this paper
• AMYOTROPHIC LATERAL SCLEROSIS: A Clinicoanatomic Study of Fifty-Three Cases

  1953cited by this paper
• Amyotrophic lateral sclerosis.

  1953cited by this paper
• AMYOTROPHIC LATERAL SCLEROSIS: ORIGIN AND EXTENT OF THE UPPER MOTOR NEURON LESION

  1941cited by this paper

• Focus on the excitatory and inhibitory neurotransmission imbalance in amyotrophic lateral sclerosis: a harmful disease player or a potential therapeutic opportunity?

  2026cites this paper
• Neuroprotective potential of epigallocatechin gallate in Neurodegenerative Diseases: Insights into molecular mechanisms and clinical Relevance.

  2025cites this paper
• Distinct Longitudinal Changes in EEG Measures Reflecting Functional Network Disruption in ALS Cognitive Phenotypes

  2024cites this paper
• Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis.

  2024cites this paper
• GABAergic inhibition shapes behavior and neural dynamics in human visual working memory

  2024cites this paper
• Sex‐related differences in amyotrophic lateral sclerosis: A 2‐[ 18F]FDG‐PET study

  2024cites this paper
• Impairments of inhibitory neurons in amyotrophic lateral sclerosis and frontotemporal dementia.

  2024cites this paper
• Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis

  2023cites this paper
• PET and SPECT Imaging of ALS: An Educational Review

  2023cites this paper
• Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective

  2022cites this paper
• The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis

  2021cites this paper
• Amiotrophic Lateral Sclerosis

  2021cites this paper
• Imaging in Amyotrophic Lateral

  2021cites this paper
• Synaptic Transmission and Motoneuron Excitability Defects in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Longitudinal surface-based spatial Bayesian GLM reveals complex trajectories of motor neurodegeneration in ALS

  2021cites this paper
• Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Structural and functional underpinnings of precentral abnormalities in amyotrophic lateral sclerosis

  2021cites this paper
• Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology.

  2021cites this paper
• Neurophysiological aspects of the completely locked-in syndrome in patients with advanced amyotrophic lateral sclerosis.

  2021cites this paper
• [123I]Iomazenil SPECT Detects a Reversible Lesion of the Left Medial Temporal Lobe in a Case of Global Autobiographical Amnesia

  2021cites this paper
• Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis

  2021cites this paper
• Neurophysiological Mechanisms Underlying Cortical Hyper-Excitability in Amyotrophic Lateral Sclerosis: A Review

  2021cites this paper
• Neurodegeneration: Diagnosis, Prevention, and Therapy

  2021cites this paper
• E cacy and Safety of Bumetanide in Patients with Amyotrophic Lateral Sclerosis: A Randomized Controlled Clinical Trial

  2021cites this paper
• Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

  2020cites this paper
• Disinhibition of sensory cortex in patients with amyotrophic lateral sclerosis.

  2020cites this paper
• How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis

  2020cites this paper
• Pathophysiological associations of transcallosal dysfunction in ALS

  2020cites this paper
• Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study

  2020cites this paper
• Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis

  2020influential citation
• Age-related increase in GABAA receptor distribution in the prefrontal cortex.

  2019cites this paper
• Biomarkers in Motor Neuron Disease: A State of the Art Review

  2019cites this paper
• Brain white matter abnormalities and correlation with severity in amyotrophic lateral sclerosis: An atlas-based diffusion tensor imaging study.

  2019cites this paper
• Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period

  2019cites this paper
• Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

  2019cites this paper
• Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis

  2019cites this paper
• Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses

  2018cites this paper
• Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis.

  2018cites this paper
• Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis

  2018cites this paper
• Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy

  2018cites this paper
• Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS

  2018influential citation
• Chapter 2 PET Imaging in ALS

  2018cites this paper
• Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis

  2018cites this paper
• Abnormal topological organization of structural covariance networks in amyotrophic lateral sclerosis

  2018cites this paper
• Motoneuron Disease: Clinical.

  2017cites this paper
• Flow-metabolism uncoupling in the cervical spinal cord of ALS patients

  2017cites this paper
• Abnormal cortical brain integration of somatosensory afferents in ALS.

  2017cites this paper
• Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia

  2017cites this paper
• Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis

  2017cites this paper
• Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1G93A mouse model of ALS

  2017cites this paper
• Oxidative stress induced by cumene hydroperoxide produces synaptic depression and transient hyperexcitability in rat primary motor cortex neurons

  2017cites this paper
• Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis

  2017cites this paper
• Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks

  2017cites this paper
• Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.

  2017cites this paper
• Investigating Default Mode and Sensorimotor Network Connectivity in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Neuroimaging in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Motor cortical function determines prognosis in sporadic ALS

  2016cites this paper
• Further development of biomarkers in amyotrophic lateral sclerosis

  2016cites this paper
• Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis

  2016cites this paper
• Altered cortical beta‐band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis

  2016cites this paper
• Excitotoxicity in ALS: Overstimulation, or overreaction?

  2016cites this paper
• Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis

  2016cites this paper
• Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis

  2016cites this paper
• Sclérose latérale amyotrophique

  2016cites this paper
• Analyse de la composition en acides gras des lipides dans la sclérose latérale amyotrophique : implications dans le processus pathologique

  2016cites this paper
• Frequency-specific alterations in the fractional amplitude of low-frequency fluctuations in amyotrophic lateral sclerosis

  2016cites this paper
• GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System.

  2015cites this paper
• Cognition and behavior in motor neuron disease

  2015cites this paper
• What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?

  2015cites this paper
• Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.

  2015cites this paper
• PET in Multiple Sclerosis

  2015cites this paper
• Amyotrophic Lateral Sclerosis: New Perpectives and Update

  2015cites this paper
• Synaptic Failure: Focus in an Integrative View of ALS

  2015cites this paper
• Biomarker development for C9orf72 repeat expansion in ALS.

  2015cites this paper
• Amyotrophic Lateral Sclerosis: An Aging-Related Disease

  2015cites this paper
• Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.

  2015cites this paper
• Role of PET and SPECT in the Study of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Neuroimaging to Investigate Multisystem Involvement and Provide Biomarkers in Amyotrophic Lateral Sclerosis

  2014cites this paper
• Resting state functional connectivity alterations in primary lateral sclerosis.

  2014cites this paper
• Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?

  2014cites this paper
• Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

  2014cites this paper
• Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes.

  2014cites this paper
• Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.

  2014cites this paper
• Neuroprotective Strategies in Amyotrophic Lateral Sclerosis: Modulation of Neurotransmittory and Neurotrophic Input to Motor Neurons

  2014cites this paper
• In Vivo Imaging in Neurodegenerative Diseases

  2014cites this paper
• Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

  2013cites this paper
• Sleep, Rapid Eye Movement, and Alertness in Patients with Amyotrophic Lateral Sclerosis

  2013cites this paper
• Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia

  2013cites this paper
• The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis

  2013cites this paper
• PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR‐WEIGHT DRUGS

  2013cites this paper
• Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?

  2013influential citation
• Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond

  2013cites this paper
• Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis.

  2013cites this paper
• Presymptomatic Imaging in ALS

  2013cites this paper
• Widespread Structural and Functional Connectivity Changes in Amyotrophic Lateral Sclerosis: Insights from Advanced Neuroimaging Research

  2012cites this paper
• Traces of disease in amyotrophic lateral sclerosis

  2012cites this paper
• Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?

  2012cites this paper
• Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Sural nerve pathology in ALS patients: a single-centre experience

  2012cites this paper
• Neuroimaging in amyotrophic lateral sclerosis.

  2012cites this paper